News
-
October 1, 2011
C-Path’s K. Romero Co-Authors Special Report- Striving for an Integrated Drug-Development Process for Neurodegeneration: the Coalition Against Major Diseases
Alzheimer’s and Parkinson’s diseases are the two main neurodegenerative disorders and despite the public health need, drug development for these conditions has been plagued by a high attrition rate in the late phases of evaluation. -
September 16, 2011
Critical Path Institute Announces Launch of Critical Path Foundation
Foundation to foster a global community of philanthropists to improve health and save lives -
September 7, 2011
Pharsight to Work with Critical Path Institute’s Polycystic Kidney Disease Consortium on Disease Progression Modeling
Pharsight, a market-leading provider of software and scientific consulting services to improve productivity and decisionmaking in clinical drug development, has announced they will be working with Critical Path Institute’s Polycystic Kidney Disease (PKD) Consortium to create and study quantitative models of disease progression in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD). -
August 1, 2011
CDISC International Interchange October 12-13 in Baltimore, MD: “Standards for Patients”
The CDISC International Interchange this fall in Baltimore will highlight “Standards for Patients”. The Conference on 12-13 October features three prominent keynote speakers, presentations from CDISC leaders and volunteers from around the globe and interactive panels on streamlining clinical research and using EHRs for research. -
June 14, 2011
Critical Path Institute and Innovative Medicines Initiative Announce Formal Collaboration
Internationally renowned organizations share common commitment to advancing science that improves medical product development. Critical Path Institute and the Innovative Medicines Initiative (IMI) announced today that they have signed a Memorandum of Understanding to further the missions of both organizations.